Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes

Bernardo Lombo, José G Díez

Core Evidence 2011, 6:31-42

Published Date: 17 March 2011